UBS AM’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
Other funds holding NERV
UBS AM's NERV Position: Q3 2026 in Review
UBS AM opened a new position in Minerva Neurosciences (NERV) in Q3 2026: 629 shares worth $2.11K. The stake represents ﹤0.01% of the portfolio and ranks #4035 among its holdings. This is a return to the name: UBS AM previously reported a position in NERV as recently as Q3 2019.
UBS AM first reported a position in NERV in Q3 2017 and has held it in 10 quarters since. The position peaked at $331K in Q3 2018. 54 funds tracked by Wall St. Rank hold NERV as of Q3 2026.
- UBS AM held 629 shares of Minerva Neurosciences worth $2.11K as of Q3 2026.
- Minerva Neurosciences was a new UBS AM position in Q3 2026.
- Minerva Neurosciences made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4035 holding.
- UBS AM first reported a position in Minerva Neurosciences in Q3 2017 and has held it in 10 quarters since.
- UBS AM's Minerva Neurosciences position peaked at $331K in Q3 2018.
- 54 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.